The ARFGAP2 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population designed for loss-of-function analysis of the ARFGAP2 gene. This polyclonal knockout pool encompasses a heterogeneous array of gene disruptions, offering a versatile model to study ARFGAP2-dependent processes without the biases of clonal selection. The population-level knockout format ensures a broad representation of editing outcomes, facilitating robust functional investigations.
HEK293T cells are immortalized human embryonic kidney epithelial cells expressing the SV40 large T-antigen, renowned for their high transfectability and capacity for protein expression and viral packaging. These cells maintain active secretory and endocytic pathways, including a functional Golgi apparatus and COPI-mediated trafficking machinery, providing a biologically relevant system to interrogate ARFGAP2 functions in epithelial cell physiology.
ARFGAP2 functions as a GTPase-activating protein (GAP) for the small GTPase ARF1, catalyzing GTP hydrolysis to trigger disassembly of the COPI coatomer complex??comprising COPA, COPB1, COPB2, COPG1, COPG2, COPE, and COPP subunits??from Golgi membranes. This activity is essential for retrograde transport from the Golgi to the endoplasmic reticulum and is regulated by membrane curvature sensors and SRC family kinases. ARFGAP2 physically interacts with ARF1 and Golgi membrane proteins, and its GAP activity is coupled to downstream SNARE-mediated membrane fusion events. Thus, ARFGAP2 serves as a critical node in COPI vesicle trafficking, integrating upstream signaling inputs to coordinate coat dynamics with cargo transport.
Disruption of ARFGAP2 in HEK293T cells is anticipated to impair COPI-dependent retrograde trafficking, leading to morphological perturbations of the Golgi network and altered protein sorting. This polyclonal knockout system allows researchers to examine the spectrum of phenotypic outcomes resulting from ARFGAP2 inactivation, mimicking the variability observed in Golgi dysfunction-associated pathologies, including neurodevelopmental disorders. The model is particularly valuable for investigating the mechanistic link between ARFGAP2-mediated coat disassembly and Golgi structural homeostasis.
Key applications include immunofluorescence microscopy to evaluate Golgi morphology, western blotting for ARF1-GTP levels, co-immunoprecipitation to probe COPI coatomer interactions, and retrograde cargo transport assays using thermosensitive viral glycoprotein reporters. These cells also facilitate screening of small-molecule modulators of the COPI pathway and in-depth mechanistic studies of vesicle biogenesis. For further information, batch-specific validation data, or assistance with experimental design, please contact Ascent Research.
